National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R05DB13	TUSSIN	G	Butamirate citrate - 7.5mg/5ml	7.5mg/5ml	Syrup, sugar free	296,925 L.L
R05DB13	TUSSIN	G	Butamirate citrate - 7.5mg/5ml	7.5mg/5ml	Syrup, sugar free	154,862 L.L
R05FA02	TUSCALMAN A	B	Noscapine HCl - 5mg, Guaifenesin - 25mg		Suppository	569,093 L.L
R05FA02	TUSCALMAN B	B	Noscapine HCl - 10mg, Guaifenesin - 50mg		Suppository	560,924 L.L
R05X	TRIMEDIL FORTE	G	O-(?-hydroxyethyl)-rutosides - 30mg, Ascorbic acid - 80mg, Dimethindene - 0.5mg, Phenylephrine HCl - 2.5mg, Paracetamol - 200mg		Capsule	386,515 L.L
R06AD08	TOPLEXIL	B	Oxomemazine HCl - 0.33mg/ml	0.33mg/ml	Syrup	615,480 L.L
S01AA09	TETRACYCLINE EYE OINTMENT	G	Tetracycline HCl - 1%	1%	Ointment	71,672 L.L
S01AA12	TOBRASTILL	G	Tobramycin - 0.3%	0.3%	Drops solution	258,018 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Ointment	280,863 L.L
S01AE06	TYMER	G	Gatifloxacin (sesquihydrate) - 3mg/ml	3mg/ml	Drops solution	427,342 L.L
S01ED51	TWINZOL	G	Dorzolamide HCl - 2%, Timolol - 0.5%		Drops solution	632,950 L.L
S01ED51	TRAVOPROST/TIMOLOL BIOGARAN	G	Travoprost - 40mcg/ml, Timolol - 5mg/ml		Drops solution	849,308 L.L
S01EE04	TRAVATAN	B	Travoprost - 40mcg/ml	0.004%	Drops solution	806,306 L.L
S01EE04	TRAVOPROST BIOGARAN		Travoprost - 40mcg/ml	40mcg/ml	Drops solution	564,414 L.L
S01FA06	TROPICIL TOP	G	Tropicamide - 10mg/ml	10mg/ml	Drops solution	200,233 L.L
S01XA20	TEARS NATURALE	B	Duasorb - 0.4%	0.4%	Drops solution	189,482 L.L
S02AA30	TYOTOCIN	B	Hexylresorcinol - 0.1%, Antipyrine - 5%, Benzocaine - 1.25%, Tyrothricin - 0.05%		Drops solution	409,552 L.L

National Cancer Registry (NCR)